Analyst Price Targets — ERAS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 13, 2026 10:43 am | Michael Schmidt | Guggenheim | $21.00 | $18.58 | StreetInsider | Erasca Inc (ERAS) PT Raised to $21 at Guggenheim |
| August 12, 2026 10:18 am | — | H.C. Wainwright | $22.00 | $18.31 | StreetInsider | Erasca Inc (ERAS) PT Raised to $22 at H.C. Wainwright |
| July 20, 2026 11:55 am | — | Morgan Stanley | $21.00 | $19.17 | TheFly | Erasca price target raised to $21 from $12 at Morgan Stanley |
| July 14, 2026 7:53 pm | — | Jefferies | $24.00 | $19.50 | StreetInsider | Erasca Inc (ERAS) PT Raised to $24 at Jefferies, 'underappreciated'Member Login |
| July 14, 2026 10:59 am | — | HSBC | $20.00 | $17.90 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on Erasca Inc (ERAS) |
| June 4, 2026 9:12 am | — | Wolfe Research | $16.00 | $13.18 | StreetInsider | BofA Securities Upgrades Erasca Inc (ERAS) to Neutral, 'we see the downside case as now less compelling' |
| May 12, 2026 11:15 am | — | Mizuho Securities | $26.00 | $10.44 | TheFly | Erasca price target lowered to $26 from $28 at Mizuho |
| April 27, 2026 10:40 am | — | Stifel Nicolaus | $30.00 | $21.50 | TheFly | Erasca price target raised to $30 from $20 at Stifel |
| March 10, 2026 6:36 pm | Laura Prendergast | Stifel Nicolaus | $20.00 | $15.58 | StreetInsider | Erasca Inc (ERAS) PT Raised to $20 at Stifel |
| January 27, 2026 12:16 pm | — | Guggenheim | $12.00 | $9.61 | TheFly | Erasca price target raised to $12 from $5 at Guggenheim |
Latest News for ERAS
SAN DIEGO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of current, long-term shareholders of Erasca, Inc. (NASDAQ: ERAS) against certain of its officers and directors for alleged breaches of fiduciary duty.
NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP , a nationally recognized investor rights law firm, announces that it is investigating potential breaches of fiduciary duty by certain directors and officers of Erasca, Inc. (“Erasca” or the “Company”) (NASDAQ: ERAS).
New York, New York--(Newsfile Corp. - August 26, 2026) - Bernstein Liebhard LLP, a nationally recognized investor rights law firm, announces that it is investigating potential breaches of fiduciary duty by certain directors and officers of Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS). The investigation seeks to determine whether the Company's leadership fulfilled its obligations to shareholders and…
BlackRock Inc. acquired a new position in Erasca, Inc. (NASDAQ: ERAS) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 21,154,146 shares of the company's stock, valued at approximately $387,544,000. BlackRock Inc. owned approximately 6.80% of Erasca at
The Alger Mid Cap 40 ETF outperformed the Russell Midcap Growth Index during the second quarter of 2026. Astera Labs, Nebius Group, and Western Digital Corporation were among the top contributors to performance. Insmed Incorporated, IREN Limited, and Erasca, Inc. were among the top detractors from performance.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ERAS.
U.S. House Trading
No House trades found for ERAS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.